Hansoh Pharmaceutical Group Company Limited (FRA:3KY)
Germany · Delayed Price · Currency is EUR 4.080
+0.020 (0.49%)
At close: Jan 30, 2026
FRA:3KY Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 4,781 | 4,372 | 3,278 | 2,584 | 2,713 | 2,569 |
Depreciation & Amortization | 381.86 | 401.35 | 366.38 | 344.6 | 278.47 | 228.23 |
Other Amortization | - | - | - | - | - | 5.04 |
Loss (Gain) From Sale of Assets | -7.13 | -5.72 | -2.1 | -11.24 | -3.94 | 0.04 |
Asset Writedown & Restructuring Costs | 4.31 | 31.98 | - | - | - | - |
Loss (Gain) From Sale of Investments | 30.07 | -61.27 | -158.22 | -67.58 | -26.28 | -87.16 |
Loss (Gain) on Equity Investments | - | - | 2.12 | 13.86 | - | - |
Stock-Based Compensation | 148.72 | 137.73 | 171.37 | 179.42 | 65.47 | 68.59 |
Provision & Write-off of Bad Debts | -27.49 | -18.18 | 22.38 | 7.15 | 0.82 | -0.31 |
Other Operating Activities | -840.84 | -1,032 | -820.19 | -2.96 | -22.01 | -176.72 |
Change in Accounts Receivable | 172.17 | 62.67 | 341.76 | 90.45 | -549.35 | -881.19 |
Change in Inventory | -75.21 | -86.73 | -129.54 | -40.94 | -111.75 | 113.77 |
Change in Accounts Payable | 94.09 | 54.09 | -58.53 | -26.03 | 123.95 | -68.47 |
Change in Unearned Revenue | 161.04 | -19.24 | 13.37 | 2.9 | -173.49 | 155.22 |
Change in Other Net Operating Assets | -37.37 | 25.38 | 90.17 | -332.15 | 282.26 | 464.52 |
Operating Cash Flow | 4,785 | 3,862 | 3,116 | 2,741 | 2,577 | 2,390 |
Operating Cash Flow Growth | 2.85% | 23.93% | 13.69% | 6.37% | 7.80% | -28.21% |
Capital Expenditures | -293.49 | -221.96 | -219.6 | -272.82 | -460.03 | -1,428 |
Sale of Property, Plant & Equipment | 6.23 | 23.96 | 10.96 | 21.1 | 54.77 | 8.07 |
Sale (Purchase) of Intangibles | -110.13 | -302.97 | -142.93 | -19 | -15.16 | -11.61 |
Investment in Securities | -5,896 | -1,988 | 647.54 | -5,846 | -2,095 | -1,664 |
Other Investing Activities | 1,027 | 1,097 | 778 | 181.17 | 256.75 | 220.63 |
Investing Cash Flow | -5,266 | -1,392 | 1,074 | -5,935 | -2,259 | -2,874 |
Short-Term Debt Issued | - | 500 | 900 | - | - | - |
Long-Term Debt Issued | - | - | - | - | 3,877 | - |
Total Debt Issued | - | 500 | 900 | - | 3,877 | - |
Short-Term Debt Repaid | - | -500 | -900 | - | - | - |
Long-Term Debt Repaid | - | -4,204 | -18.96 | -42.49 | -12.29 | -7.6 |
Total Debt Repaid | -22.4 | -4,704 | -918.96 | -42.49 | -12.29 | -7.6 |
Net Debt Issued (Repaid) | -22.4 | -4,204 | -18.96 | -42.49 | 3,865 | -7.6 |
Issuance of Common Stock | 31.18 | 33.19 | 37.99 | 13.14 | 15.11 | 3,182 |
Repurchase of Common Stock | - | -33.69 | -114.87 | -76.62 | -57.97 | - |
Common Dividends Paid | -1,858 | -1,858 | -652.08 | -712.18 | -380.87 | -4,200 |
Other Financing Activities | - | -3.21 | -5.77 | - | -24.23 | -9.55 |
Financing Cash Flow | -1,850 | -6,066 | -753.7 | -818.14 | 3,417 | -1,036 |
Foreign Exchange Rate Adjustments | -28.43 | -62.43 | -122.36 | -40.57 | -79.29 | -762.27 |
Net Cash Flow | -2,359 | -3,658 | 3,314 | -4,053 | 3,655 | -2,282 |
Free Cash Flow | 4,492 | 3,640 | 2,897 | 2,468 | 2,117 | 962.83 |
Free Cash Flow Growth | 1.54% | 25.67% | 17.36% | 16.60% | 119.88% | -64.82% |
Free Cash Flow Margin | 34.06% | 29.69% | 28.67% | 26.31% | 21.31% | 11.08% |
Free Cash Flow Per Share | 0.75 | 0.61 | 0.48 | 0.42 | 0.35 | 0.16 |
Cash Interest Paid | - | 3.21 | 5.77 | - | - | - |
Cash Income Tax Paid | 697.49 | 807.17 | 589.58 | 324.03 | 319.44 | 590.1 |
Levered Free Cash Flow | 3,288 | 2,401 | 2,069 | 1,453 | 1,256 | -3,674 |
Unlevered Free Cash Flow | 3,291 | 2,405 | 2,111 | 1,489 | 1,289 | -3,673 |
Change in Working Capital | 314.72 | 36.16 | 257.23 | -305.78 | -428.38 | -216.15 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.